January 04th 2012
BioWorld Today features AmpliPhi CEO Phil Young
BioWorld Today featured an interview of AmpliPhi CEO Phil Young by Catherine Shaffer in their November 21st, 2011 issue. The discussion includes the topic of global concerns about antibiotic resistance, the combination of Biocontrol, Ltd and Targeted Genetics, and AmpliPhi’s recent closing of a $2.7 million round of funding.
The interview also includes an update on current clinical trial progress of BioPhage-PA and pre-clinical work on BioPhage-PR, the two lead products in AmpliPhi’s current therapeutics portfolio.
Permission generously provided by BioWorld Today.
Events
March 12th 2012
Professor Mark Enright to present at University of Bath
MoreNovember 08th 2011
Dr. David Harper to present at GTC Infectious Diseases World Summit
MoreSeptember 13th 2011
Ampliphi Biosciences Corp at Rodman and Renshaw Global Investment Conference
MoreFebruary 18th 2011
Targeted Genetics Annual Shareholder Meeting Business Update Presentation
MoreJanuary 01st 1970
Professor Mark Enright to present at University of Bath
More